ArticleOncoTargets and therapy

Erratum: Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.